Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model

Bromocriptine mesylate treatment was examined in dogs fed a high fat diet (HFD) for 8 wk. After 4 wk on HFD, daily bromocriptine (Bromo; n = 6) or vehicle (CTR; n = 5) injections were administered. Oral glucose tolerance tests were performed before beginning HFD (OGTT1), 4 wk after HFD began (Bromo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Physiol Endocrinol Metab
Autors principals: Moore, Mary Courtney, Smith, Marta S., Swift, Larry L., Cincotta, Anthony H., Ezrokhi, Michael, Cominos, Nicholas, Zhang, Yahong, Farmer, Ben, Cherrington, Alan D.
Format: Artigo
Idioma:Inglês
Publicat: American Physiological Society 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7468784/
https://ncbi.nlm.nih.gov/pubmed/32459527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpendo.00479.2019
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars